Today, the U.S. Food and Drug Administration announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient (NDI) notifications.
The FDA wants consumers who use dietary supplements to know that todayโs draft guidance, if finalized, will advise the dietary supplement industry that the agency intends to exercise enforcement discretion, for a limited time and in limited circumstances, to encourage manufacturers and distributors to correct any past failures to submit a required NDI notification. By providing industry with an opportunity to correct past failures to submit required safety information, the FDA can gain more safety information about the dietary supplement marketplace and better protect public health.
โWe remain committed to a flexible framework for dietary supplements that ensures the safety of these products for consumers,โ said Cara Welch, Ph.D., director of the Office of Dietary Supplement Programs in the FDAโs Center for Food Safety and Applied Nutrition (CFSAN). โThe resulting notifications the agency receives through this period of enforcement discretion will help increase the amount of safety information we have about NDI-containing dietary supplements in the marketplace.โ
The Dietary Supplement Health and Education Act of 1994 (DSHEA) requires manufacturers and distributors who wish to market a dietary supplement containing an NDI to notify the FDA before marketing, unless a legal exception applies. The notification must contain the safety information that a manufacturer relied upon to conclude the dietary supplement containing the NDI is reasonably expected to be safe. The NDI notification process is the FDAโs only chance to evaluate the safety of a dietary supplement before it becomes available to consumers. For dietary supplements that do not contain an NDI, the law does not require manufacturers to submit safety information to the FDA before marketing. The FDA is aware that in the more than 27 years since the requirement was established, some dietary supplement firms have marketed products for which a premarket NDI notification was required, but never submitted.
The enforcement discretion policy proposed in this draft guidance relates solely to the failure to submit an NDI notification. For example, it would not extend to NDI-containing dietary supplements that are adulterated for safety reasons or that violate any other regulatory requirements that pertain to dietary supplements. This temporary policy also should help facilitate enforcement actions against those that remain out of compliance with the NDI notification requirements after the enforcement discretion period ends.
In a February 2019 statement about new efforts to strengthen the regulation of dietary supplements through modernization and reform, the FDA emphasized the need to ensure that our regulatory framework is flexible yet comprehensive enough to effectively evaluate product safety, while promoting innovation. The FDA also stated that fostering the submission of NDI notifications would be key to this effort. This draft guidance is a critical first step toward encouraging those submissions.
If the draft guidance is finalized without change, the enforcement discretion period to submit a late notification would start when the guidance is published, would last 180 days, and would apply only to products on the market when the Federal Register notice announcing the draft guidance was published. Along with this draft guidance, the FDA is also developing a new submission type through the CFSAN Online Submission Module to provide a dedicated pathway for stakeholders to electronically submit their late notifications.
Related Information
- Constituent Update
- Draft Guidance
- How to Submit Notifications for a New Dietary Ingredient
- New Dietary Ingredients (NDI) Notification Process
- New Dietary Ingredients in Dietary Supplements โ Background for Industry
- First Egyptian and Portuguese Astronauts to join Dude Perfect Cofounder on New Shepard’s 22nd FlightBlue Origin today announced the crew flying on its NS-22 mission will include Dude Perfect cofounder Coby Cotton, Portuguese entrepreneur Mรกrio Ferreira, British-American mountaineer Vanessa O’Brien, technology leader Clint Kelly III, Egyptian engineer Sara Sabry, and telecommunications executive Steve Young. Sara will become the first person from Egypt to fly to space; Mario will become the firstโฆ Read more: First Egyptian and Portuguese Astronauts to join Dude Perfect Cofounder on New Shepard’s 22nd Flight
- NASA to Host Media Activities in Houston Ahead of Lunar MissionAhead of the Artemis I flight test, NASA is inviting media to its Johnson Space Center in Houston Friday, Aug. 5, for a detailed mission briefing and a behind-the-scenes look at facilities that will enable a long-term human presence at the Moon. NASA is currently targeting no earlier than Monday, Aug. 29, for the launch of theโฆ Read more: NASA to Host Media Activities in Houston Ahead of Lunar Mission
- A Healthy Lifestyle Can Offset a High Genetic Risk for Stroke, According to New Research by UTHealth HoustonNewswise โ People who are genetically at higher risk for stroke can lower that risk by as much as 43% by adopting a healthy cardiovascular lifestyle, according to new research led by UTHealth Houston, which was published today in the Journal of the American Heart Association. The study included 11,568 adults from ages 45 to 64 whoโฆ Read more: A Healthy Lifestyle Can Offset a High Genetic Risk for Stroke, According to New Research by UTHealth Houston
- FDA Conducting Evaluation of Key Agency Activities to Strengthen OperationsIn February 2022, I rejoined the U.S. Food and Drug Administration as Commissioner of Food and Drugs, having served in the role five years earlier. Since my return, the agency has taken many significant actions that benefit the public health. Yet at the same time, the agency has confronted a series of challenges that haveโฆ Read more: FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations
- No Backhand, No Problem… A Hack for the Backhand!The latest episode of SPR! Sometimes our anticipation is off. Sometimes we are a bit slow in reacting. Sometimes we have limited mobility… and sometimes our backhand is just weak. In this episode we look at an often overlooked alternative to our backhand. SPR on Social Media: SPR Group on Facebook: https://www.facebook.com/groups/14239… SPR on TNCN:โฆ Read more: No Backhand, No Problem… A Hack for the Backhand!